F13.232
Sedative, hypnotic or anxiolytic dependence with withdrawal with perceptual disturbance
Clinical Classification Guidelines
Inclusion Terms
- Sedative, hypnotic, or anxiolytic withdrawal with perceptual disturbances
Medical Intelligence & Overview
F13.232 is an ICD-10 code used to classify a specific type of substance dependence involving sedatives, hypnotics, or anxiolytics. It indicates that an individual has developed a dependence on these medications, experiencing withdrawal symptoms that include perceptual disturbances such as hallucinations or altered perceptions. This condition highlights the complexities of substance dependency and the importance of proper management and treatment.
Causes & Symptoms
Clinical Causes: Long-term use of sedative, hypnotic, or anxiolytic medications beyond prescribed durations History of substance misuse or abuse of these medications Underlying mental health conditions that lead to increased consumption of these drugs Genetic predisposition to substance dependence Psychological reliance on sedatives or anxiolytics for managing stress, anxiety, or sleep issues
Key Symptoms: Withdrawal symptoms such as anxiety, agitation, or insomnia Perceptual disturbances, including hallucinations (visual or auditory) Confusion or disorientation Howling, trembling, or tremors Nausea, vomiting, or sweating Increased heart rate and blood pressure Disorientation or feelings of unreality Potential progression to seizures or life-threatening conditions if untreated
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough clinical assessment by a healthcare professional, including a detailed medical history and physical examination. Diagnosis often features recognizing a history of recent withdrawal from sedatives, hypnotics, or anxiolytics, coupled with observed perceptual disturbances. Additional laboratory and psychiatric evaluations may be conducted to rule out other causes and assess the extent of dependence.
Treatment Protocols: Gradual tapering of the substance to mitigate withdrawal effects Use of alternative medications or supportive drugs to control symptoms Psychological support through counseling or therapy to address underlying issues Monitoring for severe withdrawal symptoms such as seizures or psychosis Addressing co-occurring mental health conditions like anxiety or depression Long-term addiction support and relapse prevention strategies
Clinical Advice & FAQs
Billing Guidance
Is F13.232 a billable ICD-10 code?
Yes, F13.232 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.232?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with withdrawal with perceptual disturbance and any associated comorbidities for accurate reporting.
Cite this Clinical Reference